Pub. Date : 2019 Apr
PMID : 30610588
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Thus, we hypothesized that the addition of metformin to everolimus and exemestane, could lead to better outcomes in overweight and obese patients with metastatic, hormone receptor-positive, HER2-negative breast cancer. | Metformin | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |
2 | We conducted a phase II trial to evaluate the efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal women with metastatic, hormone receptor-positive, HER2-negative breast cancer. | Metformin | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |
3 | Conclusion The combination of metformin, everolimus and exemestane was safe and had moderate clinical benefit in overweight and obese with patients metastatic, hormone receptor-positive, HER2-negative breast cancer. | Metformin | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |